Tumor lysis syndrome with massive hyperphosphatemia and hyperuricemia. Clin Case Rep 2017 Dec;5(12):2158-2159
Date
12/12/2017Pubmed ID
29225880Pubmed Central ID
PMC5715431DOI
10.1002/ccr3.1268Abstract
Tumor lysis syndrome (TLS) occurs when tumor cells release their contents into the bloodstream, typically in response to chemotherapy, leading to the characteristic findings of hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney injury. Twinkle artifacts on renal ultrasound may indicate calcium phosphate deposits in such patients.